ary Madsen, Ph.D., has over 30 years of experience in developing and launching biotechnology products in a wide variety of markets at companies of various sizes. He spent 17 years at Abbott Laboratories in product support, new product development and business development. He was recruited to IDEXX Labs in Westbrook, Maine as Vice President of Research and Development.
In addition to the positions at Abbott Labs and IDEXX Labs, he has held executive positions at EraGen Biosciences (Chief Technical Officer), Promega Corp. (Director of Product and Business Development), Third Wave Technologies (Associate Vice President, Automation), Gilson Inc. (Senior Vice President, Strategic Business Development), and Biotech Resolutions, LLC (Founder).
His past successes include the development and launch of numerous regulated new products, leadership of large cross-functional teams, development and implementation of strategic plans, and consulting with a wide variety of biotech companies on critical strategic issues.
In 2012 he joined UNeMed as Entrepreneur In Residence and relocated to Omaha, NE from Madison, WI. Growing out of that role was the formation of ProTransit Nanotherapy and ProTransit Dermal Therapy with Dr. Vinod Labhasetwar in April and May, respectively, of 2013.
Dr. Madsen presented a basic overview of the company and its strategy to the local TV and radio stations following a press release regarding the licensing agreement between UNeMed and ProTransit Nanotherapy. More recently, the company was featured in an Omaha World Herald article on UNeMed.
KETV: UNMC specialists develop cutting edge sunblock lotion
KLIN radio: KLIN Radio Podcast